InvestorsHub Logo
icon url

hoarseman

06/17/14 10:56 AM

#67289 RE: TallyNole #67288

Coincidentally, the pharma company making such a drug for epilepsy also reported good news today:

"GW Pharmaceuticals PLC- ADR (NASDAQ:GWP*) reports preliminary data on 27 children and young adults with treatment-resistant epilepsy who have been treated with its investigational cannabidiol product candidate Epidiolex for a period of 12 weeks. Of the 27 patients, nine have Dravet syndrome and the remaining 18 have treatment-resistant epilepsies with convulsive and/or non-convulsive siezures.The mean overall reduction in seizure frequency compared to baseline was 44%."

I bought this stock a year or so ago at $8 and sold it at $11. What a dope.